Description

PT-141 10 mg Research Peptide USA

PT-141 10 mg, also known as Bremelanotide in scientific literature, is a synthetic melanocortin peptide supplied strictly for laboratory and scientific research purposes in the United States. This higher-strength 10 mg format is suitable for extended studies, comparative analysis, and repeated in-vitro research protocols. PT-141 is not intended for human or veterinary use and is distributed for research applications only.

Research Characteristics of PT-141

Melanocortin Pathway Research Peptide

PT-141 is widely studied in laboratory environments for its interaction with melanocortin receptors, supporting receptor-binding and signaling pathway research.

High-Purity Synthetic Production

Manufactured using controlled peptide synthesis techniques, PT-141 10 mg offers consistency, stability, and reproducibility for professional research settings.

Secure Packaging for U.S. Research Facilities

Each vial is sealed and packaged to laboratory standards to maintain peptide integrity during storage and domestic U.S. shipment.

Research Applications

PT-141 10 mg is commonly used in melanocortin receptor studies, neuropeptide signaling research, and in-vitro biochemical modeling. This compound is supplied strictly for laboratory and scientific research use only.

Advantages and Limitations

Advantages

• Higher 10 mg quantity suitable for extended research protocols
• Melanocortin-focused peptide for receptor interaction studies
• Consistent synthesis for repeatable experimental results
• Packaged to meet U.S. laboratory handling standards

Limitations

• Not approved for human, animal, or clinical use
• No therapeutic, diagnostic, or medical claims
• Restricted exclusively to laboratory research environments